Literature DB >> 2352187

On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones.

N L Harrison1.   

Abstract

1. (-)Baclofen reduces inhibitory postsynaptic potentials (IPSPs) and the associated synaptic currents (IPSCs) at inhibitory GABAergic synapses between cultured rat hippocampal neurones. The reversal potential for the IPSC is unaltered. 2. The effect of (-)baclofen is concentration dependent; the EC50 for (-)baclofen is approximately 5 microM. 3. Statistical analyses of the amplitude fluctuations of the IPSC in the presence of (-)baclofen suggested a presynaptic location for the depression of synaptic transmission by (-)baclofen. In control experiments, lowering extracellular Ca2+ produced similar effects. (-)Baclofen has no detectable postsynaptic actions in these cultured neurones. 4. Phaclofen (0.2-0.5 mM) increases IPSC amplitude but does not significantly block the depressant effect of (-)baclofen on synaptic transmission. 5. The effect of (-)baclofen is not blocked by pertussis toxin pre-treatment. 6. It is concluded that (-)baclofen acts presynaptically to reduce the release of GABA. The mechanism by which release is reduced may involve a phaclofen-insensitive GABAB receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352187      PMCID: PMC1190141          DOI: 10.1113/jphysiol.1990.sp017993

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  45 in total

1.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

2.  Synaptic interactions between mammalian central neurons in cell culture. II. Quantal Analysis of EPSPs.

Authors:  P G Nelson; K C Marshall; R Y Pun; C N Christian; W H Sheriff; R L Macdonald; E A Neale
Journal:  J Neurophysiol       Date:  1983-06       Impact factor: 2.714

3.  Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain.

Authors:  E W Karbon; S J Enna
Journal:  Mol Pharmacol       Date:  1985-01       Impact factor: 4.436

4.  gamma-aminobutyric acid B receptors are negatively coupled to adenylate cyclase in brain, and in the cerebellum these receptors may be associated with granule cells.

Authors:  W J Wojcik; N H Neff
Journal:  Mol Pharmacol       Date:  1984-01       Impact factor: 4.436

5.  Coexistence of GABAA and GABAB receptors on A delta and C primary afferents.

Authors:  M Désarmenien; P Feltz; G Occhipinti; F Santangelo; R Schlichter
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

6.  Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells.

Authors:  N R Newberry; R A Nicoll
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

7.  A bicuculline-resistant inhibitory post-synaptic potential in rat hippocampal pyramidal cells in vitro.

Authors:  N R Newberry; R A Nicoll
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

8.  Rat hippocampal neurons in culture: voltage-clamp analysis of inhibitory synaptic connections.

Authors:  M Segal; J L Barker
Journal:  J Neurophysiol       Date:  1984-09       Impact factor: 2.714

9.  Two types of gamma-aminobutyric acid receptor on embryonic sensory neurones.

Authors:  K Dunlap
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

10.  Inhibition of GABAB receptor binding by guanyl nucleotides.

Authors:  D R Hill; N G Bowery; A L Hudson
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

View more
  25 in total

1.  Involvement of protein kinase C and protein kinase A in the enhancement of L-type calcium current by GABAB receptor activation in neonatal hippocampus.

Authors:  J G Bray; M Mynlieff
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  Chronic lesion of corticostriatal fibers reduces GABAB but not GABAA binding in rat caudate putamen: an autoradiographic study.

Authors:  R Moratalla; N G Bowery
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

3.  Trends in the pathophysiology and pharmacotherapy of spasticity.

Authors:  J Noth
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

4.  GABAB receptor-mediated inhibition of Ca2+ currents and synaptic transmission in cultured rat hippocampal neurones.

Authors:  K P Scholz; R J Miller
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

5.  The modulation of rat hippocampal synaptic conductances by baclofen and gamma-aminobutyric acid.

Authors:  K W Yoon; S M Rothman
Journal:  J Physiol       Date:  1991-10       Impact factor: 5.182

6.  GABAB receptors, monoamine receptors, and postsynaptic inositol trisphosphate-induced Ca2+ release are involved in the induction of long-term potentiation at visual cortical inhibitory synapses.

Authors:  Y Komatsu
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

7.  Influx of calcium through L-type calcium channels in early postnatal regulation of chloride transporters in the rat hippocampus.

Authors:  Jennifer G Bray; Michelle Mynlieff
Journal:  Dev Neurobiol       Date:  2009-11       Impact factor: 3.964

8.  GABAB receptor-activated inwardly rectifying potassium current in dissociated hippocampal CA3 neurons.

Authors:  D L Sodickson; B P Bean
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

9.  Involvement of both GABAA and GABAB receptors in tonic inhibitory control of blood pressure at the rostral ventrolateral medulla of the rat.

Authors:  M Amano; T Kubo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

10.  Adenosine, L-AP4, and baclofen modulation of paired-pulse potentiation in the dentate gyrus: interstimulus interval-dependent pharmacology.

Authors:  J S Kahle; C W Cotman
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.